Too many still need to understand the difference between policy and health technology assessment - HTA is an instrument of policy. Stakeholders must also consider their broader responsibility to public health and how decisions in one part of the system flow onto others.
-
Latest News
'We approached stakeholders that were highly engaged with the HTA review process'
Medicines Australia will host a roundtable today to promote its three priorities for health technology assessment reform, but it has yet to disclose the names of the organisations it has selected to attend.
-
Podcast The 'Week in Review' Podcast - 26 July July 26, 2024
-
Latest News Preaching transparency and not practising it is the worst possible look July 26, 2024During the Health Technology Assessment Review, Medicines Australia repeatedly and rightly criticised its lack of transparency. It is now modelling the behaviour it consistently condemned.
-
Latest News Cartherics announces new licensing agreement for innovative cardiac cell therapy July 25, 2024Australian cell therapy company Cartherics has announced a new licensing agreement with UniQuest, the University of Queensland’s commercialisation company, and the University of Sydney.
-
Latest News These layered levels of privilege are not making decision-making or the system better July 25, 2024This previous process, which prioritised the need to secure broad industry support for reforms, has been displaced by a system of layered privilege. This is partly due to the government's more aggressive and impatient approaches to reform and partly because the industry has become more acquiescent.
-
Latest News New large study shows vaccination halves the risk of patients suffering Long-COVID July 25, 2024A new study published in the New England Journal of Medicine has found that vaccination halves the risk of Long-COVID.
-
Latest News Telix completes significant raise that could be used for acquisitions July 25, 2024Telix is commercialising its therapeutic and diagnostic radiopharmaceuticals. Its share price has more than doubled in 2024, and the company now has a market capitalisation of almost $6.4 billion.
-
Podcast The 'Dispatched' Podcast - Special Edition July 23, 2024Some parts of an institution face the challenge of avoiding complicity in wrong approaches or repeating and even adopting its exclusionary way of working. It is hard. Yet, acting in the interests of patients can require one part of the institution to act against the others. The industry is facing this challenge.
-
Latest News UK moves quickly to establish national RSV vaccination program in time for Winter July 23, 2024The vaccines are not yet included in the NIP. Still, some Australian infants have accessed the RSV vaccine through state programs, while the UK is launching a national program for infants and seniors ahead of the Northern Hemisphere Winter.
-
Latest News Centre for Sex and Gender Equity in Health and Medicine confirms leadership July 23, 2024Professor Bronwyn Graham has been appointed the director of the Centre for Sex and Gender Equity in Health and Medicine by the organisation's partners.
-
Latest News Viatris' Sylvain Vigneault on the importance of 'touch points' with the community July 22, 2024Viatris' Sylvain Vigneault told BioPharmaDispatch that the company and its employees are committed to giving back and working to a higher purpose.
-
Latest News We were promised an independent review, and this is what we got July 23, 2024Unfortunately, it is hard to imagine a process less independent than the review that delivered its final report to Health Minister Mark Butler in June.
-
Latest News Chimeric Therapeutics says first patient enrolled in cell therapy trial July 23, 2024Australian cell therapy company Chimeric Therapeutics has announced that the first patients have been enrolled in the new clinical trial of its CHM CDH17 in patients with different forms of cancer.
-
Latest News It is the institution that needs reforming, not processes and technical inputs July 21, 2024This publication has always been and remains sceptical that the Health Technology Assessment Review can deliver meaningful outcomes for patients. This scepticism is based on the fact that process and technical inputs are not the drivers of faster access but the purveyors of delay.
-
Latest News Medicines Australia to host roundtable aiming to drive HTA reform July 22, 2024Medicines Australia will host what it describes as a health technology assessment-focused roundtable this week that aims to prepare for reform.
-
Latest News Australian icon Ita Buttrose champions new RSV awareness campaign July 22, 2024GSK is partnering with former ABC chair Ita Buttrose AC OBE to launch an education campaign to raise awareness of the risks of respiratory syncytial virus infection.
-
Latest News No agreement required to deliver early patient access to neuroblastoma treatment July 19, 2024The Health Department has confirmed that the Albanese Government's commitment to reimburse the states for procuring Norgine's eflornithine (DFMO) for high-risk neuroblastoma is not covered by any agreement with the company.
-
Podcast The 'Week in Review' Podcast - 19 July July 19, 2024The combination of political will and trust should be used to help more patients. The poor treatment of a family in Western Australia, the pending departure of one of the greatest advocates for patient access, and the political realignment sending a message to companies.
-
Podcast Pink Hope CEO discusses her own experience and journey with TrailblAZers July 18, 2024TrailblAZers speaks with the CEO of Pink Hope, Sarah Powell, about her own experience and journey living with a hereditary cancer diagnosis and the current challenges Australians face in accessing genetic testing and counselling.
-
Latest News The combination of political will and trust paving the way forward on access July 19, 2024The Albanese Government's action to ensure early patient access to a yet-to-be-approved treatment for high-risk neuroblastoma and the absence of any formal agreement with the company demonstrate the apparent simplicity of establishing a 'bridging' fund.
-
Latest News Is it fair that patients are denied access to proven treatments while the NDIS funds cruises? July 18, 2024The company promotes NDIS-funded cruises to the Melbourne Cup in November, a country music festival, the Pacific Islands, and an 80s-themed cruise. Meanwhile, patients wait for funded access to proven treatments.
Australian Biotech
-
Cartherics announces new licensing agreement for innovative cardiac cell therapy
July 25, 2024 -
Chimeric Therapeutics says first patient enrolled in cell therapy trial
July 23, 2024 -
Burnet senior research officer awarded Moderna Global Fellowship
July 18, 2024 -
Alterity Therapeutics reports positive interim data from Multiple System Atrophy trial
July 18, 2024 -
Bio Innovation Hub opens opportunities for new disease treatments
July 16, 2024
Other Health
-
HCF Research Foundation hosts roundtable to advance short stay joint replacements
July 22, 2024 -
Bupa Ventures to invest $20m to accelerate healthcare innovations
February 12, 2024 -
Medibank offering members $50 to put towards dental out-of-pocket costs
February 7, 2024 -
US FDA approves Edwards' Evoque system for major heart valve disease
February 7, 2024 -
Private health insurers say price gouging doctors should be named and shamed
February 7, 2024
Latest Video
New Stories
-
The 'Week in Review' Podcast - 26 July
July 26, 2024 - - Podcast -
'We approached stakeholders that were highly engaged with the HTA review process'
July 26, 2024 - - Latest News -
Preaching transparency and not practising it is the worst possible look
July 26, 2024 - - Latest News -
Cartherics announces new licensing agreement for innovative cardiac cell therapy
July 25, 2024 - - Latest News -
New large study shows vaccination halves the risk of patients suffering Long-COVID
July 25, 2024 - - Latest News -
These layered levels of privilege are not making decision-making or the system better
July 25, 2024 - - Latest News -
Telix completes significant raise that could be used for acquisitions
July 25, 2024 - - Latest News